Avitia Launches AI-Powered Platform for Rapid & Point-of-Care Cancer Testing
February 27, 2025
Avitia's groundbreaking AI-powered cancer testing solution accelerates targeted treatments worldwide. Backed by $5M in seed funding, Avitia brings advanced, cost-effective molecular testing directly on-site, reducing turnaround times and empowering personalized oncology care. Learn more about this transformative innovation reshaping global cancer treatment.
